MALLEO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 16.842
EU - Europa 16.048
AS - Asia 11.340
SA - Sud America 1.695
Continente sconosciuto - Info sul continente non disponibili 511
AF - Africa 390
OC - Oceania 40
AN - Antartide 1
Totale 46.867
Nazione #
US - Stati Uniti d'America 16.381
RU - Federazione Russa 6.169
SG - Singapore 4.429
CN - Cina 3.228
GB - Regno Unito 2.602
IT - Italia 2.451
BR - Brasile 1.328
HK - Hong Kong 997
VN - Vietnam 994
DE - Germania 954
FR - Francia 911
IE - Irlanda 761
SE - Svezia 756
FI - Finlandia 435
BD - Bangladesh 336
KR - Corea 324
CA - Canada 241
IN - India 222
NL - Olanda 221
JP - Giappone 176
UA - Ucraina 156
MX - Messico 137
AR - Argentina 131
ES - Italia 124
TR - Turchia 101
NG - Nigeria 92
PL - Polonia 90
ID - Indonesia 89
IQ - Iraq 80
ZA - Sudafrica 71
AT - Austria 70
PK - Pakistan 59
BE - Belgio 58
EC - Ecuador 46
CZ - Repubblica Ceca 43
CO - Colombia 42
VE - Venezuela 38
TG - Togo 37
MA - Marocco 35
LT - Lituania 34
AU - Australia 33
CL - Cile 32
BJ - Benin 31
PY - Paraguay 30
CH - Svizzera 29
PH - Filippine 29
TN - Tunisia 29
UZ - Uzbekistan 29
NP - Nepal 26
EG - Egitto 25
AE - Emirati Arabi Uniti 24
JO - Giordania 24
PE - Perù 24
RO - Romania 23
SA - Arabia Saudita 23
KE - Kenya 20
DZ - Algeria 18
AZ - Azerbaigian 17
GR - Grecia 17
IL - Israele 15
MY - Malesia 15
HU - Ungheria 14
JM - Giamaica 14
LV - Lettonia 14
PT - Portogallo 14
CR - Costa Rica 13
KG - Kirghizistan 12
TH - Thailandia 12
AL - Albania 11
NO - Norvegia 11
DK - Danimarca 10
IR - Iran 10
KZ - Kazakistan 10
RS - Serbia 10
SI - Slovenia 10
BG - Bulgaria 9
HR - Croazia 9
UY - Uruguay 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
PS - Palestinian Territory 8
HN - Honduras 7
OM - Oman 7
PR - Porto Rico 7
BB - Barbados 6
LB - Libano 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
EE - Estonia 5
GT - Guatemala 5
NI - Nicaragua 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
BH - Bahrain 4
GA - Gabon 4
GY - Guiana 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
Totale 46.281
Città #
Singapore 2.308
Moscow 2.174
Southend 2.152
Ashburn 2.047
Dallas 1.818
San Jose 1.573
Chandler 1.499
Hong Kong 975
Verona 810
Council Bluffs 781
Dublin 736
Beijing 600
Jacksonville 509
The Dalles 509
Woodbridge 494
New York 432
Houston 375
Ho Chi Minh City 344
Los Angeles 324
Ann Arbor 306
Munich 293
Lawrence 243
Princeton 243
Wilmington 218
Hanoi 215
Jinan 215
Nanjing 178
Helsinki 175
Santa Clara 171
Shenyang 157
São Paulo 157
Boardman 144
Tokyo 143
Buffalo 142
Redondo Beach 141
Milan 137
Orem 136
Hebei 118
Redmond 111
Columbus 101
Sindelfingen 96
London 94
Tianjin 94
Turku 94
Rome 87
Seattle 86
Montreal 84
Abuja 83
Frankfurt am Main 83
Haikou 79
Hangzhou 73
Chennai 71
Zhengzhou 69
Ningbo 68
Phoenix 68
Warsaw 68
Changsha 67
Amsterdam 66
Atlanta 66
Bologna 66
Denver 66
San Francisco 65
Chicago 63
Toronto 62
Brooklyn 61
Stockholm 61
Guangzhou 57
Fairfield 54
Nanchang 53
Poplar 53
Brussels 52
Mexico City 51
Da Nang 50
Taizhou 49
Falkenstein 48
Redwood City 48
Johannesburg 47
Lancaster 47
Seoul 47
Rio de Janeiro 46
Haiphong 45
Taiyuan 45
Jiaxing 44
Nuremberg 42
Washington 41
Mumbai 38
Vienna 38
Baghdad 37
Belo Horizonte 37
Lomé 37
Paris 37
Jakarta 34
Lappeenranta 34
Manchester 34
Cotonou 31
Boston 28
Istanbul 28
Norwalk 28
Brasília 26
Fuzhou 26
Totale 27.556
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 986
STUDIO PROSPETTICO MULTICENTRICO SULLA GESTIONE DEI DRENAGGI DOPO DUODENOCEFALOPANCREASECTOMIA UTILIZZANDO UN SISTEMA DI STRATIFICAZIONE DEL RISCHIO 719
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 395
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohort 301
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 293
Genomic characterization of hepatoid tumors: context matters 262
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 256
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 255
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 253
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 253
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 252
Gα15 in early onset of pancreatic ductal adenocarcinoma 244
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 241
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 238
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 235
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 235
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 229
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 222
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 222
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 221
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 221
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 221
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 219
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 219
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 216
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 214
Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases 213
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 211
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts 211
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 211
Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy 208
Delaying surgery for patients with a previous SARS-CoV-2 infection 208
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 208
Acute pancreatitis at the beginning of the 21st century: the state of the art. 207
Sex differences in oncogenic mutational processes 207
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 206
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 204
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 202
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 200
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 196
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 196
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 195
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 195
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 194
Efficacy of Endoscopic Minor Papilla Sphincterotomy for Symptomatic Santorinicele Endoscopic treatment of Santorinicele 191
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 191
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 190
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 188
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 187
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 187
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 187
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 187
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 187
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 186
Results of a surveillance protocol for pancreatic BD-IPMNs 186
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 186
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 185
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 184
An unforeseeable adverse event during ERCP 183
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 183
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 182
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 181
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 179
Serous Cystic Neoplasms 179
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 179
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 179
Imaging after pancreatic surgery: normal post-operative findings, early and late complications with emphasis on CT imaging 178
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 178
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 178
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar 178
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 178
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification 177
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 176
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 176
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 176
Solid-pseudopapillary, Acinar, and Other Cystic Neoplasms 175
Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery 175
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 175
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 175
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data 174
Immune performance profile in pancreatic adenocarcinoma patients. 173
Cystic Neoplasm of the Pancreas 173
Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or~Tail on Surgical and Oncological Outcome: A Propensity-Score~Matched Multicenter Study 172
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 171
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 171
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 170
The management of intraductal papillary mucinous neoplasms of the pancreas 170
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons 170
Non-inferiority of open passive drains compared with closed suction drains in pancreatic surgery outcomes: A prospective observational study 170
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 168
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 167
The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis 167
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 167
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 167
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 167
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 166
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 166
Quantitative Assessment of Pancreatic Texture Using a Durometer: A New Tool to Predict the Risk of Developing a Postoperative Fistula 165
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 165
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 165
Totale 21.200
Categoria #
all - tutte 163.105
article - articoli 153.689
book - libri 0
conference - conferenze 2.541
curatela - curatele 0
other - altro 2.322
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.553
Totale 326.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.644 0 448 51 139 59 34 33 127 98 51 139 465
2022/20234.811 291 521 401 765 398 1.324 114 307 473 53 97 67
2023/20242.660 88 217 261 277 281 417 169 221 47 102 429 151
2024/20256.738 356 335 248 1.027 359 203 420 345 996 497 664 1.288
2025/202622.558 1.417 1.390 1.636 3.575 5.367 1.410 1.880 1.330 1.927 1.322 517 787
2026/20271.102 472 630 0 0 0 0 0 0 0 0 0 0
Totale 46.867